NasdaqCM - Nasdaq Real Time Price USD

Aurora Cannabis Inc. (ACB)

5.95

+0.13

+(2.23%)

At close: June 10 at 4:00:01 PM EDT

Aurora Expands Medical Cannabis Offerings in Australia with the Launch of IndiMed TEMPO 22

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has expanded their popular IndiMed brand with the launch of IndiMed TEMPO 22, available through the company's subsidiary, MedReleaf Australia. With the same consistent quality and reliable supply, this new 22% THC potency creates a greater range of treatment options available to prescribers.

PR Newswire 5 days ago

ACB
+2.23%
Jim Cramer Says Aurora Cannabis Inc. (ACB) Stock is “a Nice Speculative Stock”

We recently published a list of Jim Cramer Talked About These 16 Stocks Recently. In this article, we are going to take a look at where Aurora Cannabis Inc. (NASDAQ:ACB) stands against other stocks that Jim Cramer discussed recently. When a caller inquired about Aurora Cannabis Inc. (NASDAQ:ACB), Cramer commented: “You know, I keep thinking […]

Insider Monkey 5 days ago

ACB
+2.23%
Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2025 Investor Conference Call and File Related Year End Information

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and fiscal year 2025 on Wednesday, June 18, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the fourth quarter fiscal year 2025 before the opening of markets that same day.

CNW Group 7 days ago

ACB
+2.23%
Aurora to Participate in TD Cowen's 9th Annual Future of the Consumer Conference

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, will participate in TD Cowen's 9th Annual Future of the Consumer Conference in New York City, NY. Simona King, Chief Financial Officer at Aurora, will take part in a fireside chat and one-on-one meetings with investors on June 3, 2025, at 2:45pm EST.

PR Newswire 14 days ago

ACB
+2.23%
Rubicon Organics Announces Appointment of Glen Ibbott as Interim CFO

VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, today announced the appointment of Glen Ibbott, a cannabis industry veteran and former Chief Financial Officer of Aurora Cannabis Inc. (TSX: ACB, Nasdaq: ACB) as its Interim Chief Financial Officer. Janis Risbin, current CFO, will be stepping aw

GlobeNewswire 26 days ago

ACB
+2.23%

ROMJF
Higher Returns with Aurora Cannabis – Initiation Report

Visit Exec Edge Research for Full Report By Rayk Riechmann Investors want what they’re on! Aurora Cannabis Inc. (Nasdaq: ACB), a federally-licensed producer of medical and consumer cannabis, is attractively positioned as an early leader in global regulated markets. ACB leverages a best-in-class brand portfolio to grow and sell products across all major cannabis categories. […]

Exec Edge last month

ACB
+2.23%
Is Aurora Cannabis Inc. (ACB) Among the Best Tobacco and Cigarette Stocks to Buy Now?

We recently compiled a list of the 10 Best Tobacco and Cigarette Stocks to Buy Now. In this article, we are going to take a look at where Aurora Cannabis Inc. (NASDAQ:ACB) stands against the other Tobacco and Cigarette stocks. Cigarette and tobacco stocks are companies that produce and sell cigars, snuff, chewing tobacco, cigarettes, e-cigarettes, […]

Insider Monkey last month

ACB
+2.23%
Aurora Cannabis Announces the Completion of a Multimillion Dollar Investment and Renaming of B.C. Manufacturing Facility

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces the completion of a multi-year investment of $3 million in improvements to its manufacturing facility in Pemberton, British Columbia. These upgrades are a combination of Aurora's proprietary high-performing genetics and state-of-the-art engineering design which have resulted in optimal cultivation conditions, expanded output, and superior product quality. The site has been renamed

CNW Group last month

ACB
+2.23%
Aurora Cannabis Introduces the Company's First Inhalable Resin Cartridges for Patients in the United Kingdom

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has announced today the availability of medical cannabis concentrates to patients in the United Kingdom (UK). This launch marks the company's meaningful step in offering its proprietary cultivar-specific inhalable cannabis extracts in the UK market. These products are available to patients in Canada and Australia and this launch reinforces Aurora's commitment to expanding patient access to

CNW Group last month

ACB
+2.23%
Aurora Cannabis Recognized for Executive Gender Diversity by The Globe and Mail

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has been named an honouree on the Globe & Mail's 2025 Report on Business, Women Lead Here list. This annual editorial benchmark recognizes the top publicly traded Canadian companies with the highest gender diversity at the executive level.

CNW Group 2 months ago

ACB
+2.23%
Is Aurora Cannabis Inc. (ACB) the Best Cannabis Stock to Buy According to Billionaires?

We recently published a list of 12 Best Cannabis Stock to Buy According to Billionaires. In this article, we are going to take a look at where Aurora Cannabis Inc. (NASDAQ:ACB) stands against other best marijuana stocks to invest in according to billionaires. 2025 didn’t start off very well for the American cannabis sector. The recent […]

Insider Monkey 2 months ago

ACB
+2.23%
Aurora Cannabis to Speak at the Global Cannabis Regulatory Summit

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to be attending, sponsoring and speaking at the 2025 Global Cannabis Regulatory Summit (GCRS), held within the U.S. Capitol Complex in Washington, D.C. on March 26-27, 2025.

CNW Group 2 months ago

ACB
+2.23%
TPB, ACB and JAZZ: Three Pot Stocks Flowering With Potential Upside

After bursting onto the scene several years ago with considerable fanfare, much of the hype about cannabis stocks has quietly died down, and share prices have largely followed suit. Here, we’ll examine three profitable and cheap cannabis-related stocks that offer investors long-term value and potential upside: Turning Point Brands (TPB), Aurora Cannabis (ACB), and Jazz Pharmaceuticals (JAZZ). Cannabis Potential Released From Government Dungeons Having been illegal for decades, cannabis is seeing

TipRanks 2 months ago

JAZZ

TPB

ACB
+2.23%
Aurora Cannabis Announces Breakthrough Discovery of Powdery Mildew Resistant Cultivars

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's discovery of a novel source of genetic resistance against powdery mildew, PM2, that provides strong protection against this pathogen in cannabis sativa. The development of this proprietary genetic marker technology, which is now in use in Aurora's breeding program, is set to produce powdery mildew resistant cultivars that will be explored for commercial

PR Newswire 2 months ago

ACB
+2.23%
Aurora Cannabis Rides the Global Legalization Wave: Should You Invest?

ACB capitalizes on the rapidly evolving medical cannabis landscape, leveraging its EU GMP-certified manufacturing facilities, advanced genetics and deep regulatory knowledge.

Zacks 2 months ago

ACB
+2.23%
Are Medical Stocks Lagging Aurora Cannabis (ACB) This Year?

Here is how Aurora Cannabis Inc. (ACB) and Concentra Group (CON) have performed compared to their sector so far this year.

Zacks 2 months ago

ACB
+2.23%
Is Aurora Cannabis (ACB) Stock Outpacing Its Medical Peers This Year?

Here is how Aurora Cannabis Inc. (ACB) and AdaptHealth Corp. (AHCO) have performed compared to their sector so far this year.

Zacks 3 months ago

ACB
+2.23%

AHCO
Wall Street Analysts Predict a 25.67% Upside in Aurora Cannabis (ACB): Here's What You Should Know

The mean of analysts' price targets for Aurora Cannabis (ACB) points to a 25.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks 3 months ago

ACB
+2.23%
Best Momentum Stocks to Buy for February 21st

ACB, BHRB and BJ made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 21, 2024.

Zacks 3 months ago

BJ

ACB
+2.23%
Best Value Stocks to Buy for February 21st

ACB, and PRTH made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 21, 2024.

Zacks 3 months ago

ACB
+2.23%

PRTHU

Performance Overview

Return	ACB	S&P/TSX Composite index (^GSPTSE)
YTD	+41.67%	+7.33%
1-Year	+1.02%	+19.74%
3-Year	-57.50%	+30.34%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Aurora Cannabis Inc. (ACB)

Aurora Expands Medical Cannabis Offerings in Australia with the Launch of IndiMed TEMPO 22

Jim Cramer Says Aurora Cannabis Inc. (ACB) Stock is “a Nice Speculative Stock”

Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2025 Investor Conference Call and File Related Year End Information

Aurora to Participate in TD Cowen's 9th Annual Future of the Consumer Conference

Rubicon Organics Announces Appointment of Glen Ibbott as Interim CFO

Higher Returns with Aurora Cannabis – Initiation Report

Is Aurora Cannabis Inc. (ACB) Among the Best Tobacco and Cigarette Stocks to Buy Now?

Aurora Cannabis Announces the Completion of a Multimillion Dollar Investment and Renaming of B.C. Manufacturing Facility

Aurora Cannabis Introduces the Company's First Inhalable Resin Cartridges for Patients in the United Kingdom

Aurora Cannabis Recognized for Executive Gender Diversity by The Globe and Mail

Is Aurora Cannabis Inc. (ACB) the Best Cannabis Stock to Buy According to Billionaires?

Aurora Cannabis to Speak at the Global Cannabis Regulatory Summit

TPB, ACB and JAZZ: Three Pot Stocks Flowering With Potential Upside

Aurora Cannabis Announces Breakthrough Discovery of Powdery Mildew Resistant Cultivars

Aurora Cannabis Rides the Global Legalization Wave: Should You Invest?

Are Medical Stocks Lagging Aurora Cannabis (ACB) This Year?

Is Aurora Cannabis (ACB) Stock Outpacing Its Medical Peers This Year?

Wall Street Analysts Predict a 25.67% Upside in Aurora Cannabis (ACB): Here's What You Should Know

Best Momentum Stocks to Buy for February 21st

Best Value Stocks to Buy for February 21st

Performance Overview